{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,23]],"date-time":"2026-05-23T12:05:32Z","timestamp":1779537932067,"version":"3.53.1"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,8,9]],"date-time":"2025-08-09T00:00:00Z","timestamp":1754697600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,8,9]],"date-time":"2025-08-09T00:00:00Z","timestamp":1754697600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82204220"],"award-info":[{"award-number":["82204220"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Sichuan Science and Technology Program","award":["2023NSFSC1689"],"award-info":[{"award-number":["2023NSFSC1689"]}]},{"name":"the Natural Science Foundation of Chongqing Science and Technology Bureau","award":["CSTB2024NSCQ-MSX0769"],"award-info":[{"award-number":["CSTB2024NSCQ-MSX0769"]}]},{"name":"the Natural Science Foundation of Chongqing Science and Technology Bureau","award":["cstc2022ycjh-bgzxm0170"],"award-info":[{"award-number":["cstc2022ycjh-bgzxm0170"]}]},{"name":"the Natural Science Foundation of Chongqing Science and Technology Bureau","award":["cstc2022ycjh-bgzxm0170"],"award-info":[{"award-number":["cstc2022ycjh-bgzxm0170"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Divers"],"DOI":"10.1007\/s11030-025-11312-5","type":"journal-article","created":{"date-parts":[[2025,8,9]],"date-time":"2025-08-09T10:39:00Z","timestamp":1754735940000},"page":"3597-3614","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Multicomponent reaction synthesis and evaluation of novel 3,4-dihydropyrazine[1,2-b]Indazole-1(2H)-one derivatives as inhibitors of pyroptosis and inflammation"],"prefix":"10.1007","volume":"30","author":[{"given":"Zhen","family":"Dai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donglin","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiping","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jihong","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"DianYong","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhigang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongzhu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,9]]},"reference":[{"key":"11312_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ddtec.2018.11.002","volume":"29","author":"E Ruijter","year":"2018","unstructured":"Ruijter E, Orru R, Synthetic, BioOrganic Chemistry G (2018) Multicomponent reactions in drug discovery and medicinal chemistry. Drug Discov Today Technol 29:1\u20132. https:\/\/doi.org\/10.1016\/j.ddtec.2018.11.002","journal-title":"Drug Discov Today Technol"},{"key":"11312_CR2","doi-asserted-by":"publisher","first-page":"4895","DOI":"10.1039\/d4qo01060d","volume":"11","author":"X Tang","year":"2024","unstructured":"Tang X, Tao Q, Song L, Van der Eycken EV (2024) Recent advances in post Ugi-4CR dearomatizations for constructing spiro heterocycles. Org Chem Front 11:4895\u20134912. https:\/\/doi.org\/10.1039\/d4qo01060d","journal-title":"Org Chem Front"},{"key":"11312_CR3","doi-asserted-by":"publisher","DOI":"10.1002\/tcr.202300095","volume":"23","author":"X Tang","year":"2023","unstructured":"Tang X, Song L, Van der Eycken EV (2023) Post-Ugi cyclizations towards polycyclic N-heterocycles. Chem Rec 23:e202300095. https:\/\/doi.org\/10.1002\/tcr.202300095","journal-title":"Chem Rec"},{"key":"11312_CR4","doi-asserted-by":"publisher","first-page":"5460","DOI":"10.1039\/d1qo00313e","volume":"8","author":"JC Flores-Reyes","year":"2021","unstructured":"Flores-Reyes JC, Islas-J\u00e1come A, Gonz\u00e1lez-Zamora E (2021) The Ugi three-component reaction and its variants. Org Chem Front 8:5460\u20135515. https:\/\/doi.org\/10.1039\/d1qo00313e","journal-title":"Org Chem Front"},{"key":"11312_CR5","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1007\/s11030-017-9811-2","volume":"22","author":"J Lei","year":"2018","unstructured":"Lei J, Meng JP, Tang DY, Frett B, Chen ZZ et al (2018) Recent advances in the development of polycyclic skeletons via Ugi reaction cascades. Mol Divers 22:503\u2013516. https:\/\/doi.org\/10.1007\/s11030-017-9811-2","journal-title":"Mol Divers"},{"key":"11312_CR6","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1038\/s41392-021-00658-5","volume":"6","author":"H Zhao","year":"2021","unstructured":"Zhao H, Wu L, Yan G, Chen Y, Zhou M et al (2021) Inflammation and tumor progression: signaling pathways and targeted intervention. Signal Transduct Target Ther 6:263. https:\/\/doi.org\/10.1038\/s41392-021-00658-5","journal-title":"Signal Transduct Target Ther"},{"key":"11312_CR7","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1126\/science.abi5200","volume":"374","author":"R Medzhitov","year":"2021","unstructured":"Medzhitov R (2021) The spectrum of inflammatory responses. Science 374:1070\u20131075. https:\/\/doi.org\/10.1126\/science.abi5200","journal-title":"Science"},{"key":"11312_CR8","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.immuni.2019.06.025","volume":"51","author":"FR Greten","year":"2019","unstructured":"Greten FR, Grivennikov SI (2019) Inflammation and cancer: triggers, mechanisms, and consequences. Immunity 51:27\u201341. https:\/\/doi.org\/10.1016\/j.immuni.2019.06.025","journal-title":"Immunity"},{"key":"11312_CR9","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1038\/s41575-023-00769-0","volume":"20","author":"LM Hegarty","year":"2023","unstructured":"Hegarty LM, Jones GR, Bain CC (2023) Macrophages in intestinal homeostasis and inflammatory bowel disease. Nat Rev Gastroenterol Hepatol 20:538\u2013553. https:\/\/doi.org\/10.1038\/s41575-023-00769-0","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"11312_CR10","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.immuni.2021.12.013","volume":"55","author":"TV Rohm","year":"2022","unstructured":"Rohm TV, Meier DT, Olefsky JM, Donath MY (2022) Inflammation in obesity, diabetes, and related disorders. Immunity 55:31\u201355. https:\/\/doi.org\/10.1016\/j.immuni.2021.12.013","journal-title":"Immunity"},{"key":"11312_CR11","doi-asserted-by":"publisher","DOI":"10.1007\/s00401-024-02790-2","volume":"148","author":"P Botella Lucena","year":"2024","unstructured":"Botella Lucena P, Heneka MT (2024) Inflammatory aspects of Alzheimer\u2019s disease. Acta Neuropathol 148:31. https:\/\/doi.org\/10.1007\/s00401-024-02790-2","journal-title":"Acta Neuropathol"},{"key":"11312_CR12","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.888392","volume":"13","author":"DD Arnold","year":"2022","unstructured":"Arnold DD, Yalamanoglu A, Boyman O (2022) Systematic review of safety and efficacy of IL-1-targeted biologics in treating immune-mediated disorders. Front Immunol 13:888392. https:\/\/doi.org\/10.3389\/fimmu.2022.888392","journal-title":"Front Immunol"},{"key":"11312_CR13","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1093\/rheumatology\/keq031","volume":"49","author":"T Horiuchi","year":"2010","unstructured":"Horiuchi T, Mitoma H, Harashima S, Tsukamoto H, Shimoda T (2010) Transmembrane TNF-alpha: structure, function and interaction with anti-TNF agents. Rheumatology (Oxford) 49:1215\u20131228. https:\/\/doi.org\/10.1093\/rheumatology\/keq031","journal-title":"Rheumatology (Oxford)"},{"key":"11312_CR14","doi-asserted-by":"publisher","first-page":"2338","DOI":"10.1016\/S0140-6736(17)31491-5","volume":"389","author":"GR Burmester","year":"2017","unstructured":"Burmester GR, Pope JE (2017) Novel treatment strategies in rheumatoid arthritis. Lancet 389:2338\u20132348. https:\/\/doi.org\/10.1016\/S0140-6736(17)31491-5","journal-title":"Lancet"},{"key":"11312_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmc.2024.117899","volume":"112","author":"M Arfeen","year":"2024","unstructured":"Arfeen M, Srivastava A, Srivastava N, Khan RA, Almahmoud SA et al (2024) Design, classification, and adverse effects of NSAIDs: a review on recent advancements. Bioorg Med Chem 112:117899. https:\/\/doi.org\/10.1016\/j.bmc.2024.117899","journal-title":"Bioorg Med Chem"},{"key":"11312_CR16","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1038\/s41392-024-01757-9","volume":"9","author":"Q Guo","year":"2024","unstructured":"Guo Q, Jin Y, Chen X, Ye X, Shen X et al (2024) NF-kappaB in biology and targeted therapy: new insights and translational implications. Signal Transduct Target Ther 9:53. https:\/\/doi.org\/10.1038\/s41392-024-01757-9","journal-title":"Signal Transduct Target Ther"},{"key":"11312_CR17","doi-asserted-by":"publisher","first-page":"14447","DOI":"10.1021\/acs.jmedchem.3c01370","volume":"66","author":"N Li","year":"2023","unstructured":"Li N, Zhang R, Tang M, Zhao M, Jiang X et al (2023) Recent progress and prospects of small molecules for NLRP3 inflammasome inhibition. J Med Chem 66:14447\u201314473. https:\/\/doi.org\/10.1021\/acs.jmedchem.3c01370","journal-title":"J Med Chem"},{"key":"11312_CR18","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1038\/s41573-023-00822-2","volume":"23","author":"L Vande Walle","year":"2024","unstructured":"Vande Walle L, Lamkanfi M (2024) Drugging the NLRP3 inflammasome: from signalling mechanisms to therapeutic targets. Nat Rev Drug Discov 23:43\u201366. https:\/\/doi.org\/10.1038\/s41573-023-00822-2","journal-title":"Nat Rev Drug Discov"},{"key":"11312_CR19","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1178662","volume":"14","author":"Z Dai","year":"2023","unstructured":"Dai Z, Liu WC, Chen XY, Wang X, Li JL et al (2023) Gasdermin D-mediated pyroptosis: mechanisms, diseases, and inhibitors. Front Immunol 14:1178662. https:\/\/doi.org\/10.3389\/fimmu.2023.1178662","journal-title":"Front Immunol"},{"key":"11312_CR20","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1038\/s44161-022-00108-7","volume":"1","author":"M Su","year":"2022","unstructured":"Su M, Chen C, Li S, Li M, Zeng Z et al (2022) Gasdermin D-dependent platelet pyroptosis exacerbates NET formation and inflammation in severe sepsis. Nat Cardiovasc Res 1:732\u2013747. https:\/\/doi.org\/10.1038\/s44161-022-00108-7","journal-title":"Nat Cardiovasc Res"},{"key":"11312_CR21","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1038\/s41418-021-00916-7","volume":"29","author":"X Sun","year":"2022","unstructured":"Sun X, Liu Y, Huang Z, Xu W, Hu W et al (2022) SARS-CoV-2 non-structural protein 6 triggers NLRP3-dependent pyroptosis by targeting ATP6AP1. Cell Death Differ 29:1240\u20131254. https:\/\/doi.org\/10.1038\/s41418-021-00916-7","journal-title":"Cell Death Differ"},{"key":"11312_CR22","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.750841","volume":"12","author":"H Gao","year":"2021","unstructured":"Gao H, Cao M, Yao Y, Hu W, Sun H et al (2021) Dysregulated microbiota-driven gasdermin D activation promotes colitis development by mediating IL-18 release. Front Immunol 12:750841. https:\/\/doi.org\/10.3389\/fimmu.2021.750841","journal-title":"Front Immunol"},{"key":"11312_CR23","doi-asserted-by":"publisher","first-page":"1971","DOI":"10.3892\/or.2018.6634","volume":"40","author":"J Gao","year":"2018","unstructured":"Gao J, Qiu X, Xi G, Liu H, Zhang F et al (2018) Downregulation of GSDMD attenuates tumor proliferation via the intrinsic mitochondrial apoptotic pathway and inhibition of EGFR\/Akt signaling and predicts a good prognosis in nonsmall cell lung cancer. Oncol Rep 40:1971\u20131984. https:\/\/doi.org\/10.3892\/or.2018.6634","journal-title":"Oncol Rep"},{"key":"11312_CR24","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1111\/imr.12534","volume":"277","author":"SM Man","year":"2017","unstructured":"Man SM, Karki R, Kanneganti TD (2017) Molecular mechanisms and functions of pyroptosis, inflammatory caspases and inflammasomes in infectious diseases. Immunol Rev 277:61\u201375. https:\/\/doi.org\/10.1111\/imr.12534","journal-title":"Immunol Rev"},{"key":"11312_CR25","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1038\/nature15514","volume":"526","author":"J Shi","year":"2015","unstructured":"Shi J, Zhao Y, Wang K, Shi X, Wang Y et al (2015) Cleavage of GSDMD by inflammatory caspases determines pyroptotic cell death. Nature 526:660\u2013665. https:\/\/doi.org\/10.1038\/nature15514","journal-title":"Nature"},{"key":"11312_CR26","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/j.tibs.2016.10.004","volume":"42","author":"J Shi","year":"2017","unstructured":"Shi J, Gao W, Shao F (2017) Pyroptosis: gasdermin-mediated programmed necrotic cell death. Trends Biochem Sci 42:245\u2013254. https:\/\/doi.org\/10.1016\/j.tibs.2016.10.004","journal-title":"Trends Biochem Sci"},{"key":"11312_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.mam.2020.100890","volume":"76","author":"S Xia","year":"2020","unstructured":"Xia S (2020) Biological mechanisms and therapeutic relevance of the gasdermin family. Mol Aspects Med 76:100890. https:\/\/doi.org\/10.1016\/j.mam.2020.100890","journal-title":"Mol Aspects Med"},{"key":"11312_CR28","doi-asserted-by":"publisher","first-page":"1633","DOI":"10.1126\/science.abb9818","volume":"369","author":"F Humphries","year":"2020","unstructured":"Humphries F, Shmuel-Galia L, Ketelut-Carneiro N, Li S, Wang B et al (2020) Succination inactivates gasdermin D and blocks pyroptosis. Science 369:1633\u20131637. https:\/\/doi.org\/10.1126\/science.abb9818","journal-title":"Science"},{"key":"11312_CR29","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1038\/s41590-020-0669-6","volume":"21","author":"JJ Hu","year":"2020","unstructured":"Hu JJ, Liu X, Xia S, Zhang Z, Zhang Y et al (2020) FDA-approved disulfiram inhibits pyroptosis by blocking gasdermin D pore formation. Nat Immunol 21:736\u2013745. https:\/\/doi.org\/10.1038\/s41590-020-0669-6","journal-title":"Nat Immunol"},{"key":"11312_CR30","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.aat2738","volume":"3","author":"JK Rathkey","year":"2018","unstructured":"Rathkey JK, Zhao J, Liu Z, Chen Y, Yang J, Kondolf HC, Benson BL, Chirieleison SM, Huang AY, Dubyak GR, Xiao TS, Li X, Abbott DW (2018) Chemical disruption of the pyroptotic pore-forming protein gasdermin D inhibits inflammatory cell death and sepsis. Sci Immunol 3:eaat2738. https:\/\/doi.org\/10.1126\/sciimmunol.aat2738","journal-title":"Sci Immunol"},{"key":"11312_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioorg.2025.108477","volume":"160","author":"Z Dai","year":"2025","unstructured":"Dai Z, Wang K, Bai C, Li Y, Yu Q et al (2025) Discovery of a novel thiazole amide inhibitor of Inflammasome and Pyroptosis pathways. Bioorg Chem 160:108477. https:\/\/doi.org\/10.1016\/j.bioorg.2025.108477","journal-title":"Bioorg Chem"},{"key":"11312_CR32","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1038\/s41577-019-0165-0","volume":"19","author":"KV Swanson","year":"2019","unstructured":"Swanson KV, Deng M, Ting JP (2019) The NLRP3 inflammasome: molecular activation and regulation to therapeutics. Nat Rev Immunol 19:477\u2013489. https:\/\/doi.org\/10.1038\/s41577-019-0165-0","journal-title":"Nat Rev Immunol"},{"key":"11312_CR33","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1038\/s41589-019-0277-7","volume":"15","author":"RC Coll","year":"2019","unstructured":"Coll RC, Hill JR, Day CJ, Zamoshnikova A, Boucher D et al (2019) MCC950 directly targets the NLRP3 ATP-hydrolysis motif for inflammasome inhibition. Nat Chem Biol 15:556\u2013559. https:\/\/doi.org\/10.1038\/s41589-019-0277-7","journal-title":"Nat Chem Biol"},{"key":"11312_CR34","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1038\/nm.3806","volume":"21","author":"RC Coll","year":"2015","unstructured":"Coll RC, Robertson AA, Chae JJ, Higgins SC, Mu\u00f1oz-Planillo R, Robertson AAB, Inserra MC, Vetter I, Dungan LS, Monks BG, Stutz A, Croker DE, Butler MS, Haneklaus M, Sutton CE, N\u00fa\u00f1ez G, Latz E, Kastner DL, Mills KHG, Masters SL, Schroder K, Cooper MA, O\u2019Neill LAJ (2015) A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases. Nat Med 21:248\u2013255. https:\/\/doi.org\/10.1038\/nm.3806","journal-title":"Nat Med"},{"key":"11312_CR35","doi-asserted-by":"publisher","DOI":"10.15252\/emmm.201708689","volume":"10","author":"Y Huang","year":"2018","unstructured":"Huang Y, Jiang H, Chen Y, Wang X, Yang Y et al (2018) Tranilast directly targets NLRP3 to treat inflammasome-driven diseases. EMBO Mol Med 10:e8689. https:\/\/doi.org\/10.15252\/emmm.201708689","journal-title":"EMBO Mol Med"},{"key":"11312_CR36","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.1021\/acs.jmedchem.3c02098","volume":"67","author":"J Velcicky","year":"2024","unstructured":"Velcicky J, Janser P, Gommermann N, Brenneisen S, Ilic S et al (2024) Discovery of potent, orally bioavailable, tricyclic NLRP3 inhibitors. J Med Chem 67:1544\u20131562. https:\/\/doi.org\/10.1021\/acs.jmedchem.3c02098","journal-title":"J Med Chem"},{"key":"11312_CR37","doi-asserted-by":"publisher","first-page":"3219","DOI":"10.1084\/jem.20171419","volume":"214","author":"H Jiang","year":"2017","unstructured":"Jiang H, He H, Chen Y, Huang W, Cheng J et al (2017) Identification of a selective and direct NLRP3 inhibitor to treat inflammatory disorders. J Exp Med 214:3219\u20133238. https:\/\/doi.org\/10.1084\/jem.20171419","journal-title":"J Exp Med"},{"key":"11312_CR38","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1111\/j.1574-695X.2007.00329.x","volume":"51","author":"P Tripathi","year":"2007","unstructured":"Tripathi P, Tripathi P, Kashyap L, Singh V (2007) The role of nitric oxide in inflammatory reactions. FEMS Immunol Med Microbiol 51:443\u2013452. https:\/\/doi.org\/10.1111\/j.1574-695X.2007.00329.x","journal-title":"FEMS Immunol Med Microbiol"},{"key":"11312_CR39","doi-asserted-by":"publisher","first-page":"e08","DOI":"10.15171\/ipp.2019.08","volume":"5","author":"S Papi","year":"2019","unstructured":"Papi S, Ahmadizar F, Hasanvand A (2019) The role of nitric oxide in inflammation and oxidative stress. Immunopathol Persa 5:e08\u2013e08. https:\/\/doi.org\/10.15171\/ipp.2019.08","journal-title":"Immunopathol Persa"},{"key":"11312_CR40","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1016\/j.drudis.2011.06.004","volume":"16","author":"YL Bennani","year":"2011","unstructured":"Bennani YL (2011) Drug discovery in the next decade: innovation needed ASAP. Drug Discov Today 16:779\u2013792. https:\/\/doi.org\/10.1016\/j.drudis.2011.06.004","journal-title":"Drug Discov Today"},{"key":"11312_CR41","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1016\/j.chembiol.2014.08.013","volume":"21","author":"BC Doak","year":"2014","unstructured":"Doak BC, Over B, Giordanetto F, Kihlberg J (2014) Oral druggable space beyond the rule of 5: insights from drugs and clinical candidates. Chem Biol 21:1115\u20131142. https:\/\/doi.org\/10.1016\/j.chembiol.2014.08.013","journal-title":"Chem Biol"},{"key":"11312_CR42","doi-asserted-by":"publisher","DOI":"10.7860\/jcdr\/2018\/31817.11764","author":"S Shreshtha","year":"2018","unstructured":"Shreshtha S, Sharma P, Kumar P, Sharma R, Singh SP (2018) Nitric oxide: it\u2019s role in immunity. J Clin Diagn Res. https:\/\/doi.org\/10.7860\/jcdr\/2018\/31817.11764","journal-title":"J Clin Diagn Res"}],"container-title":["Molecular Diversity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11030-025-11312-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11030-025-11312-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11030-025-11312-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,23]],"date-time":"2026-05-23T11:34:10Z","timestamp":1779536050000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11030-025-11312-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,9]]},"references-count":42,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2026,6]]}},"alternative-id":["11312"],"URL":"https:\/\/doi.org\/10.1007\/s11030-025-11312-5","relation":{},"ISSN":["1573-501X"],"issn-type":[{"value":"1573-501X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,9]]},"assertion":[{"value":"10 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}